Male sexual function in presymptomatic gene carriers and patients with Huntington's disease

被引:9
|
作者
Kolenc, Matej [1 ]
Kobal, Jan [2 ]
Podnar, Simon [3 ]
机构
[1] Gen Hosp Novo Mesto, Dept Neurol, SI-8000 Novo Mesto, Slovenia
[2] Univ Med Ctr Ljubljana, Div Neurol, Clin Dept Vasc Neurol & Intens Neurol Therapy, Ljubljana, Slovenia
[3] Univ Med Ctr Ljubljana, Div Neurol, Inst Clin Neurophysiol, Ljubljana, Slovenia
关键词
Erection; Huntington's disease; Male sexual dysfunction; Sexual questionnaire; Deterioration of sexual function; Autonomic dysfunction; Depression; Total functional capacity; MOUSE MODEL; TRACK-HD; DYSFUNCTION; TESTOSTERONE; CONSEQUENCES; PREMANIFEST; PROGRESSION; PREDICTORS; DEPRESSION; SYMPTOMS;
D O I
10.1016/j.jns.2015.11.015
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aims: To report sexual dysfunction in a systematically studied cohort of men with Huntington's disease (HD), and compare them with control men of a similar age. Methods: In men with HD and asymptomatic HD gene carriers, the male sexual dysfunction questionnaire (International Index of Erectile Function-IIEF, covering erectile and orgasmic function, sexual desire, intercourse satisfaction and overall satisfaction), neurologic assessment using the Unified Huntington's Disease Rating Scale (UHDRS) and the Total Functional Capacity (TFC) Score were utilized. Results: Responses were obtained from 23 HD patients and 2 HD gene carriers. HD patients reported more problems with erection, intercourse satisfaction and overall satisfaction (p<0.05) compared to 41 controls. HD patients generally reported reduced sexual desire and performance. Sexual dysfunction progressed in parallel with patients' decline in motor (UHDRS) and TFC, but was not related to patients' age and duration of disease. Conclusions: Our study demonstrated a significant impact of HD on male sexual function that progressed in parallel with motor and total patient (TFC) dysfunction. Physicians helping HD patients should also consider this largely neglected aspect of the disease. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:312 / 317
页数:6
相关论文
共 50 条
  • [21] Decreased Diffusivity in the Caudate Nucleus of Presymptomatic Huntington Disease Gene Carriers: Which Explanation?
    Mandelli, M. L.
    Savoiardo, M.
    Minati, L.
    Mariotti, C.
    Aquino, D.
    Erbetta, A.
    Genitrini, S.
    Di Donato, S.
    Bruzzone, M. G.
    Grisoli, M.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2010, 31 (04) : 706 - 710
  • [22] Oxidative stress in Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects
    Klepac, N.
    Relja, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 11 - 11
  • [23] Microstructural white matter changes in presymptomatic Huntington's disease gene carriers: A diffusion tensor imaging study
    Feigin, A
    Kingsley, PB
    Ma, YL
    Okulsky, J
    Paulsen, JS
    Guttman, M
    Carbon, M
    Eidelberg, D
    NEUROLOGY, 2004, 62 (07) : A202 - A202
  • [24] Odor identification in Huntington's disease patients and asymptomatic gene carriers
    Bylsma, FW
    Moberg, PJ
    Doty, RL
    Brandt, J
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1997, 9 (04) : 598 - 600
  • [25] Cognitive function in presymptomatic Huntington's disease: A double-blind comparison between carriers and non-carriers in Norwegian individuals
    van Walsem, M.
    Retterstol, L.
    Sundet, K.
    Sundseth, O.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 : A9 - A9
  • [26] Functional imaging of cognitive processes in Huntington's disease and its presymptomatic mutation carriers
    Wolf, R. C.
    Vasic, N.
    Schoenfeldt-Lecuona, C.
    Ecker, D.
    Landwehrmeyer, G. B.
    NERVENARZT, 2008, 79 (04): : 408 - +
  • [27] A FREQUENCY OF CONCOMITANT DISORDERS IN PRESYMPTOMATIC HUNTINGTON'S DISEASE PATIENTS
    Puch, Elzbieta Alicja
    Witkowski, Grzegorz
    Isalan, Mark
    Mielcarek, Michal
    Zielonka, Daniel
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A42 - A43
  • [28] Are gait initiation parameters early markers of Huntington's disease in presymptomatic mutation carriers?
    Delval, Arnaud
    Bleuse, Severine
    Simonin, Clemence
    Defebvre, Luc
    Duiardin, Kathy
    Krystkowiak, Pierre
    NEUROLOGY, 2008, 70 (11) : A435 - A435
  • [29] Microglial activation in presymptomatic Huntington's disease gene carriers:: A 11C-PK11195 pet study
    Tai, YF
    Pavese, N
    Gerhard, A
    Tabrizi, SJ
    Barker, RA
    Brooks, DJ
    Piccini, P
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
  • [30] Proximity to clinical onset influences motor and cognitive performance in presymptomatic Huntington disease gene carriers
    Farrow, Maree
    Chua, Phyllis
    Churchyard, Andrew
    Bradshaw, John L.
    Chiu, Edmond
    Georgiou-Karistianis, Nellie
    COGNITIVE AND BEHAVIORAL NEUROLOGY, 2006, 19 (04) : 208 - 216